University Professor (W3) for "Medical Data Science in Oncology"

University Professor (W3) for "Medical Data Science in Oncology"

Reference number: 2025-0050

Essen
Vollzeit
Scientific Director

Apply now

“Research for a life without cancer" is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.

The National Center for Tumor Diseases (NCT), the University of Duisburg-Essen (Faculty of Medicine), and the German Cancer
Research Center (DKFZ) are jointly appointing to the earliest possible date a new

(joint appointment according to the Jülich model)

The tenured professorship (employment status) will be located at the National Center for Tumor Diseases (NCT), site NCT West (Essen campus).

The National Center for Tumor Diseases (NCT) is a long-term cooperation between the German Cancer Research Center (DKFZ),
excellent partners in university medicine and other outstanding research partners at various locations in Germany. With a
focus on innovative clinical trials, the NCT enables new developments from the laboratory to be tested clinically quickly and
to the highest standards, thereby making better diagnostic and treatment options available to patients. Special emphasis will be
placed on personalized oncology, patient participation as research partners, rapid and fair patient access to advances in cancer
research, and the training of future generations of clinical cancer researchers. As part of the National Decade against Cancer
initiated by the German Federal Ministry of Education and Research (BMBF), the NCT has been expanded for this purpose. There
are four new NCT sites in addition to Heidelberg and Dresden: Berlin, SouthWest (Tübingen/Stuttgart-Ulm), WERA (Würzburg
with partners Erlangen, Regensburg, and Augsburg), and West (Essen/Köln).

The new professorship will be located at the NCT West (Essen Campus) and is embedded in the Institute for Artificial Intelligence
in Medicine (https://www.ikim.uk-essen.de), which is part of the Faculty of Medicine and the University Hospital Essen (https:// www.uk-essen.de/). Upon completion generous space will be provided in the new NCT building in Essen. The professorship
is embedded in the Faculty of Medicine and the University Hospital Essen with its excellent research environment in cancer
medicine including the West German Cancer Center (Oncology Center of Excellence of the German Cancer Aid), the NCT West
and the partner site of the German Cancer Consortium (DKTK, https://dktk.dkfz.de/en/sites/essen-duesseldorf). There is a close
connection with the University of Cologne and the University Hospital Cologne as well as the German Cancer Research Center
in Heidelberg (DKFZ, https://www.dkfz.de/en/index.html) as the other joint sponsors of the
NCT West (https://nct.dkfz.de/en/ sites/translate-to-english-nct-west.html). The NCT professorship is assigned to a DKFZ research program and the data science
cross-section program (https://www.dkfz.de/en/index.html).

We are looking for an internationally recognized scientist with outstanding expertise in developing and applying state-of-the-art
machine learning and artificial intelligence methods in medicine. The successful candidate is expected to apply these newly
developed methods to unique existing multimodal data obtained from clinical care (https://www.ume.de/smart-hospital/) and
science in order to develop novel methods for the diagnosis, therapy and understanding of oncological diseases. In addition to
scientific excellence, the ability to communicate and collaborate with clinical partners and other scientific institutions nationally
and internationally is of great importance. The professorship is expected to lead the development and integration of medical
data sciences in oncology across all NCT sites for easy access and ethical use by next generation data scientists. The professor
will also develop and validate AI/machine learning-based tools for the NCT‘s data-informed academic trial portfolio.

The successful candidate is expected to manage the team in a responsible economic, goal- and employee-oriented manner,
and to provide an inclusive work environment by taking active steps to achieve equity and attract, develop and promote people
from diverse backgrounds.

The Faculty of Medicine at the University of Duisburg-Essen is internationally renowned for its clinical, translational, and basic
research. Key research areas include „Cardiovascular Diseases“, „Immunology and Infectiology“, „Oncology“, „Translational Neuroand
Behavioral Sciences“, and „Transplantation“. The advertised professorship is assigned to the research focus on oncology.

Publications in high-ranking, peer-reviewed journals are expected, as well as experience commensurate with professional
experience in the implementation of self-acquired competitively reviewed third-party projects, preferably in programs funded
by the Deutsche Forschungsgemeinschaft (DFG), the European Research Council (ERC) or international funding organisations.

The University of Duisburg-Essen attaches particular importance to the quality of teaching. Didactic ideas on teaching – also
taking into account the profile of the University of Duisburg-Essen – must be presented. An active contribution to the NCT
School of Clinical Cancer Research is also expected.

The recruitment requirements are based on Section 36 of the NRW Higher Education Act.and the DKFZ statutes. The joint
appointment will follow the “Jülicher Modell”, where the successful candidate will be appointed as a full and lifetime professor
at University Duisburg-Essen and then, granted a leave of absence to the DKFZ, which will be the employer. The permanent
position at the level of a DKFZ head of division is endowed with attractive core funding including personnel, consumable and
investments.

The University of Duisburg-Essen and the DKFZ aim to promote the diversity of its members (see http://uni-due.de/diversity and https://www.dkfz.de/en/gleichstellungsbeauftragte/index.html). They endeavour to increase the proportion of women
among their academic staff and therefore strongly encourage relevantly qualified women to apply. Women with equal
qualifications will be given preferential consideration in accordance with the State Equal Opportunities Act. Applications from
suitable severely disabled persons and persons of equal status within the meaning of § 2 (3) SGB IX are welcome.

Applications with the following documents (curriculum vitae, list of scientific publications (see http://www.uni-due.de/ imperia/md/content/medizin/formblatt_aufbau_schriftenverzeichnis.pdf), documents on your academic and professional
career, copies of certificates, a description of your own research profile and the resulting perspectives at the University of
Duisburg-Essen, information on third-party funds raised, participation in academic self- administration, previous teaching
activities and teaching concept) as well as a selection of the 5 most important publications should be sent by 10 April 2025
to Univ.-Prof. Dr. med. Jan Buer, Dean of the Faculty of Medicine, University Hospital Essen, Hufelandstr. 55, 45147 Essen
by e-mail to Berufungen@uk-essen.de and additionally via the application form at https://www.uni-due.de/med/de/organisation/bewerbungsbogen.php, and to Prof. Dr. Dr. h.c. Michael Baumann, Chairman and Scientific Director of the
German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg exclusively in electronic form, stating
the reference number via the DKFZ online application tool (https://www.dkfz.de/en/stellenangebote/index.php).

Further information on the position, its integration into the University of Duisburg-Essen and the faculty can be found at
https://www.uni-due.de/med/de/organisation/berufungen.php).

Are you interested?

Then become part of the DKFZ and join us in contributing to a life without cancer!

**Contact:**Prof. Dr. med. Dr. h.c. Michael Baumann
Telefon: +49 (0)6221/42-2850

Duration: The position is permanent.

Application Deadline: 10.04.2025

Applications by e-mail cannot be accepted.

We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.

Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.